سعر ايموكسكلاف 312مجم/5مل 60 مل معلق 2024

Amoxicillin/clavulanate product (E-moxclav 312 mg/5ml dry mix for oral susp. 60 ml) by EIPICO.

• Treatment of infections due to susceptible beta-lactamase-producing organisms as labeled for amoxicillin/clavulanate (e.g., lower respiratory tract infections, acute bacterial otitis media, sinusitis, skin and skin structure infections, urinary tract infections).Population: Adults and pediatric patients as labeledDailyMed (U.S. NLM)

• Common: diarrhea, nausea, vomiting, mucocutaneous candidiasis, rash. Serious: hepatic reactions, severe cutaneous adverse reactions, antibiotic-associated colitis.International label, same formulation · DailyMed (U.S. NLM)

• History of serious hypersensitivity reaction to amoxicillin, clavulanate, or other beta-lactam antibiotics; history of cholestatic jaundice/hepatic dysfunction associated with amoxicillin/clavulanate.International label, same formulation · DailyMed (U.S. NLM)

• Hepatic dysfunction (including hepatitis and cholestatic jaundice) has been associated with amoxicillin/clavulanate; Clostridium difficile-associated diarrhea; serious hypersensitivity reactions possible.International label, same formulation · DailyMed (U.S. NLM)

• Available data with amoxicillin/clavulanate have not established a drug-associated risk of major birth defects or miscarriage; use only if clearly needed per clinical judgment.International label, same formulation · DailyMed (U.S. NLM)
• Amoxicillin is excreted in human milk; clavulanate excretion not fully characterized; possible sensitization/diarrhea/candidiasis in the infant; use with caution.International label, same formulation · DailyMed (U.S. NLM)

• Amoxicillin: Bactericidal beta-lactam that inhibits bacterial cell-wall biosynthesis during active multiplication; inactivated by beta-lactamases (US label, section 12.4).
• Clavulanic acid: Beta-lactam that inactivates some beta-lactamases, protecting amoxicillin from degradation.